Skip to main content
Premium Trial:

Request an Annual Quote

CareDx: Ankur Dhingra

CareDx has appointed Ankur Dhingra as its new CFO, effective March 25. As CFO, Dhingra will lead CareDx's global finance organization including treasury, tax, and other corporate functions, and will report directly to President and CEO Reg Seeto.

Dhingra has more than 25 years of finance and accounting experience. He most recently served as vice president of investor relations at Agilent Technologies. Prior to that, he worked as group CFO for Agilent's life sciences and applied markets business unit.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.